Patents by Inventor Tamara Miskowski

Tamara Miskowski has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8372973
    Abstract: The present invention relates to certain novel compounds of Formula (I): and methods for preparing these compounds, compositions, intermediates and derivatives thereof and for the treatment of prokineticin 1 or prokinetin 1 receptor mediated disorders.
    Type: Grant
    Filed: December 16, 2010
    Date of Patent: February 12, 2013
    Assignee: Janssen Pharmaceutica N.V.
    Inventors: Steven J. Coats, Alexey B. Dyatkin, Wei He, Joseph Lisko, Tamara Miskowski, Janet L. Ralbovsky, Mark Schulz
  • Publication number: 20120028997
    Abstract: The present invention relates to certain novel compounds of Formula (I): and methods for preparing these compounds, compositions, intermediates and derivatives thereof and for the treatment of prokineticin 1 or prokinetin 1 receptor mediated disorders.
    Type: Application
    Filed: December 16, 2010
    Publication date: February 2, 2012
    Inventors: Steven J. Coats, Alexey B. Dyatkin, Wei He, Joseph Lisko, Tamara Miskowski, Janet L. Ralbovsky, Mark Schulz
  • Patent number: 7902358
    Abstract: The present invention relates to certain novel compounds of Formula (I): and methods for preparing these compounds, compositions, intermediates and derivatives thereof and for the treatment of prokineticin 1 or prokinetin 1 receptor mediated disorders.
    Type: Grant
    Filed: December 28, 2006
    Date of Patent: March 8, 2011
    Assignee: Janssen Pharmaceutica NV
    Inventors: Steven J. Coats, Alexey B. Dyatkin, Wei He, Joseph Lisko, Tamara Miskowski, Janet L. Ralbovsky, Mark Schulz
  • Publication number: 20080287445
    Abstract: The present invention relates to certain novel compounds of Formula (I): and methods for the treatment of prokineticin 2 or prokinetin 2 receptor mediated disorders.
    Type: Application
    Filed: December 28, 2006
    Publication date: November 20, 2008
    Inventors: Steven J. Coats, Alexey B. Dyatkin, Wei He, Joseph Lisko, Tamara Miskowski, Janet L. Ralbovsky, Mark Schulz
  • Publication number: 20080269225
    Abstract: The present invention relates to certain novel compounds of Formula (I): and methods for preparing these compounds, compositions, intermediates and derivatives thereof and for the treatment of prokineticin 1 or prokinetin 1 receptor mediated disorders.
    Type: Application
    Filed: December 28, 2006
    Publication date: October 30, 2008
    Inventors: Steven J. Coats, Alexey B. Dyatkin, Wei He, Joseph Lisko, Tamara Miskowski, Janet L. Ralbovsky, Mark Schulz
  • Publication number: 20080045535
    Abstract: The present invention relates to certain novel compounds of Formula (I): and methods for preparing these compounds, compositions, intermediates and derivatives thereof and for the treatment of prokineticin 2 or prokinetin 2 receptor mediated disorders.
    Type: Application
    Filed: March 14, 2006
    Publication date: February 21, 2008
    Inventors: Steven Coats, Alexey Dyatkin, Wei He, Joseph Lisko, Tamara Miskowski, Janet Ralbovsky, Mark Schulz
  • Publication number: 20060235018
    Abstract: The present invention relates to certain novel compounds of Formula (I): and methods for preparing these compounds, compositions, intermediates and derivatives thereof and for the treatment of prokineticin 1 or prokinetin 1 receptor mediated disorders.
    Type: Application
    Filed: March 14, 2006
    Publication date: October 19, 2006
    Inventors: Steven Coats, Alexey Dyatkin, Wei He, Joseph Lisko, Tamara Miskowski, Janet Ralbovsky, Mark Schulz
  • Publication number: 20060223846
    Abstract: The invention is directed to aza-bridged-bicyclic compounds having Formula (I): and pharmaceutically acceptable salts thereof. The compounds are useful ?4 integrin receptor antagonists and, in particular, ?4?1 and ?4?7 integrin receptor antagonists. The invention is further directed to methods for use of the instant compounds for treating integrin mediated disorders including, but not limited to, inflammatory disorders, autoimmune disorders and cell-proliferative disorders, methods for preparing the compounds and methods for preparing the intermediates, derivatives and pharmaceutical compositions thereof.
    Type: Application
    Filed: March 8, 2006
    Publication date: October 5, 2006
    Inventors: Alexey Dyatkin, Yong Gong, Wei He, Tamara Miskowski
  • Publication number: 20050192279
    Abstract: The present invention relates to certain novel compounds of Formula (I): methods for preparing these compounds, compositions, intermediates and derivatives thereof and for the treatment of integrin mediated disorders.
    Type: Application
    Filed: February 9, 2005
    Publication date: September 1, 2005
    Inventors: Kent Barbay, Alexey Dyatkin, Yong Gong, Wei He, Tamara Miskowski
  • Publication number: 20050176755
    Abstract: The invention is directed to aza-bridged-bicyclic compounds having Formula (I): and pharmaceutically acceptable salts thereof. The compounds are useful ?4 integrin receptor antagonists and, in particular, ?4?1 and ?4?7 integrin receptor antagonists. The invention is further directed to methods for use of the instant compounds for treating integrin mediated disorders including, but not limited to, inflammatory disorders, autoimmune disorders and cell-proliferative disorders, methods for preparing the compounds and methods for preparing the intermediates, derivatives and pharmaceutical compositions thereof.
    Type: Application
    Filed: October 27, 2004
    Publication date: August 11, 2005
    Inventors: Alexey Dyatkin, Yong Gong, Tamara Miskowski, Wei He